Literature DB >> 35922689

LUHMES Dopaminergic Neurons Are Uniquely Susceptible to Ferroptosis.

Zhi-Bin Tong1, Hyunhee Kim1, Lara El Touny1, Anton Simeonov1, David Gerhold2.   

Abstract

Ferroptosis is a necrotic cell death caused by lipid oxidation that may be responsible for neural degeneration in Parkinson's disease. We assessed whether three neuronal cell lines are sensitive to killing by ferroptosis. Ferroptosis inducer erastin killed LUHMES neurons at sub-micromolar concentrations, whereas neuronal cells derived from SH-SY5Y cells or neural stem cells were at least 50-fold less sensitive. LUHMES differentiated neurons were likewise sensitive to killing by RSL3 or ML210, inhibitors of the glutathione peroxidase 4 enzyme (GPX4) that consumes GSH to detoxify lipid peroxides. Additional assays showed that erastin, RSL3, and ML210 increased lipid peroxide levels, and that LUHMES neurons were protected from both peroxide accumulation and cell death by ferrostatin-1. A possible role of iron was assessed by evaluating the effects of five metal chelators on cytotoxicity of erastin and RSL3. LUHMES neurons were protected from RSL3 by three of the chelators, 2,3-dimercapto-1-propanesulfonic acid (DMPS), deferoxiprone (DFX), and deferiprone (DFP). Collectively, these results demonstrate the vulnerability of LUHMES neurons to ferroptosis by chemical treatments that disrupt glutathione synthesis, lipid peroxide detoxification, or iron metabolism. The same vulnerabilities may occur in CNS neurons, which reportedly generate low levels of GSH and metallothioneins, limiting their ability to neutralize oxidative stresses and toxic metals. These results suggest a rationale and methods to search for environmental toxicants that may exploit these vulnerabilities and promote neurodegenerative diseases.
© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Entities:  

Keywords:  Ferroptosis; LUHMES; Metal chelators; Neurodegeneration; Parkinson’s disease

Mesh:

Substances:

Year:  2022        PMID: 35922689      PMCID: PMC9576307          DOI: 10.1007/s12640-022-00538-y

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.978


  26 in total

Review 1.  Oxidative stress and regulated cell death in Parkinson's disease.

Authors:  P A Dionísio; J D Amaral; C M P Rodrigues
Journal:  Ageing Res Rev       Date:  2021-02-01       Impact factor: 10.895

2.  Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway.

Authors:  Julie Lotharius; Jeppe Falsig; Johan van Beek; Sarah Payne; Ralf Dringen; Patrik Brundin; Marcel Leist
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

3.  Generation of Mitochondrial Toxin Rodent Models of Parkinson's Disease Using 6-OHDA , MPTP , and Rotenone.

Authors:  Hiroharu Maegawa; Hitoshi Niwa
Journal:  Methods Mol Biol       Date:  2021

4.  The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons.

Authors:  D Ben-Shachar; G Eshel; J P Finberg; M B Youdim
Journal:  J Neurochem       Date:  1991-04       Impact factor: 5.372

5.  Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis.

Authors:  Wan Seok Yang; Katherine J Kim; Michael M Gaschler; Milesh Patel; Mikhail S Shchepinov; Brent R Stockwell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-09       Impact factor: 11.205

6.  Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death.

Authors:  Samantha Giordano; Jisun Lee; Victor M Darley-Usmar; Jianhua Zhang
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

7.  MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis.

Authors:  Konstantinos V Floros; JinYang Cai; Sheeba Jacob; Richard Kurupi; Carter K Fairchild; Mayuri Shende; Colin M Coon; Krista M Powell; Benjamin R Belvin; Bin Hu; Madhavi Puchalapalli; Sivapriya Ramamoorthy; Kimberly Swift; Janina P Lewis; Mikhail G Dozmorov; John Glod; Jennifer E Koblinski; Sosipatros A Boikos; Anthony C Faber
Journal:  Cancer Res       Date:  2021-01-22       Impact factor: 13.312

8.  RSL3 and Erastin differentially regulate redox signaling to promote Smac mimetic-induced cell death.

Authors:  Jasmin Dächert; Hannah Schoeneberger; Katharina Rohde; Simone Fulda
Journal:  Oncotarget       Date:  2016-09-27

9.  Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants.

Authors:  Simon Gutbier; Sotiris Kyriakou; Stefan Schildknecht; Anna-Katharina Ückert; Markus Brüll; Frank Lewis; David Dickens; Liam Pearson; Joanna L Elson; Sylvia Michel; Véronique Hubscher-Bruder; Jeremy Brandel; David Tetard; Marcel Leist; Ilse S Pienaar
Journal:  Arch Toxicol       Date:  2020-06-30       Impact factor: 5.153

10.  Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models.

Authors:  Rachid Skouta; Scott J Dixon; Jianlin Wang; Denise E Dunn; Marina Orman; Kenichi Shimada; Paul A Rosenberg; Donald C Lo; Joel M Weinberg; Andreas Linkermann; Brent R Stockwell
Journal:  J Am Chem Soc       Date:  2014-03-14       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.